D. Lucas Kerr

Also affiliated with University of Washington, UCSF Helen Diller Family Comprehensive Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance”.

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Nature Genetics(2023)10.1038/s41588-023-01592-8

N/A

1.9DataRank · unranked

88 citations

Philippe Gui, Manasi K. Mayekar, Emily K. Law, Oriol Pich, Chris Bailey +80 more

Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study

Journal of Clinical Oncology(2024)10.1200/jco.24.00071

N/A

1.4DataRank · unranked

60 citations

Anatoly Urisman, Matthew A. Gubens, Claire K. Mulvey, Greg M. Allen, Stephen Shiboski +19 more

Supplementary Figure from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

(2023)10.1158/2159-8290.22541643

N/A

0.128DataRank · unranked

1 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

(2023)10.1158/2159-8290.22541649

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Figshare(2023)10.1158/2159-8290.22541646.v1

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Figshare(2023)10.1158/2159-8290.22541652.v1

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

(2023)10.1158/2159-8290.22541646

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Supplementary Figure from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Figshare(2023)10.1158/2159-8290.22541643.v1

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.18.423280

N/A

0DataRank · unranked

19 citations

Deborah R. Caswell, Natalie I. Vokes, Emily K. Law, Wei Wu, William Hill +43 more

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR mutant lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.26.356352

N/A

0DataRank · unranked

1 citations

Wei Wu, Niki Karachaliou, Collin M. Blakely, Junji Suzuki, Siraj M. Ali +14 more

Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment

Current Opinion in Chemical Biology(2021)10.1016/j.cbpa.2020.11.007

N/A

0DataRank · unranked

123 citations

Franziska Haderk, Trever G. Bivona, D. Lucas Kerr

Acid-Sensitive Surfactants Enhance the Delivery of Nucleic Acids

Molecular Pharmaceutics(2021)10.1021/acs.molpharmaceut.1c00579

N/A

0DataRank · unranked

14 citations

Hesong Han, Jie Li, D. Lucas Kerr, Chung Taing, Kamyar Behrouzi +10 more

A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.23.465573

N/A

0DataRank · unranked

18 citations

Celia Fernández-Méndez, Lauren Čech, Johnny Yu, Ismail M. Meraz, Victor Olivas +28 more

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer

Journal of Clinical Investigation(2022)10.1172/jci145099

N/A

0DataRank · unranked

57 citations

Wei Wu, Niki Karachaliou, Collin M. Blakely, Junji Suzuki, Yu‐Ting Chou +23 more

Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells

Science Translational Medicine(2022)10.1126/scitranslmed.abc7480

N/A

0DataRank · unranked

45 citations

Min Lu, Hazel X. Ang, Ryan S. Soderquist, Christine E. Eyler, Haley M. Hutchinson +12 more

A self-immolative linker that releases thiols detects penicillin amidase and nitroreductase with high sensitivity via absorption spectroscopy

Chemical Communications(2022)10.1039/d1cc05322a

N/A

0DataRank · unranked

3 citations

Joachim Justad Røise, Maomao He, I-Che Li, Alvin K. Agatep, Patrick Udenyi +9 more

Predicting patient treatment response and resistance via single-cell transcriptomics of their tumors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e20540

N/A

0DataRank · unranked

5 citations

Rahulsimham Vegesna, Saugato Rahman Dhruba, Wei Wu, D. Lucas Kerr, Oleg V. Stroganov +9 more

Predicting patient treatment response and resistance via single-cell transcriptomics of their tumors

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.11.475728

N/A

0DataRank · unranked

3 citations

Rahulsimham Vegesna, Saugato Rahman Dhruba, Wei Wu, D. Lucas Kerr, Oleg V. Stroganov +9 more

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer

Nature Communications(2024)10.1038/s41467-024-47423-0

N/A

0DataRank · unranked

88 citations

Yu‐Ting Chou, Lauren Čech, Celia Fernández-Méndez, Johnny Yu, Victor Olivas +30 more

CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.12.584638

N/A

0DataRank · unranked

3 citations

Philippe Gui, Wei Wu, D. Lucas Kerr, Lisa Tan, Dora Barbosa +10 more

Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

(2023)10.1158/2159-8290.c.6549711.v1

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies

Research Square(2025)10.21203/rs.3.rs-5135027/v1

N/A

0DataRank · unranked

0 citations

Tadashi Manabe, Hannah C. Bergo, Qingtian Li, Tim Sen Wang, Paul Severson +19 more

Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

(2023)10.1158/2159-8290.c.6549711

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Figshare(2023)10.1158/2159-8290.22541649.v1

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more